Taoka Chemical (4113) Fundamentals 2026 — P/E 7.7x, Revenue Analysis | SniperIQ
Taoka Chemical (4113) is a JP-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥11.8B, trading at ¥823.00 on the JPX. This SniperIQ fundamentals page covers Taoka Chemical's valuation (P/E 7.7x, P/B 0.6x), profitability (net margin 4.6%), revenue (¥33.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Taoka Chemical's market cap?
Taoka Chemical (4113) has a market capitalization of approximately ¥11.8B, trading at ¥823.00 on the JPX. Market cap moves with the live share price.
What is Taoka Chemical's P/E ratio?
Taoka Chemical's trailing twelve-month P/E ratio is 7.7x, with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Taoka Chemical?
Taoka Chemical runs a net profit margin of 4.6%, a gross margin of 17.4%, and an operating margin of 6.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Taoka Chemical generate?
Taoka Chemical reported revenue of ¥33.2B for fiscal year 2025, with net income of ¥1.5B and earnings per share (EPS) of 106.99. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Taoka Chemical pay a dividend?
Taoka Chemical offers a trailing dividend yield of about 4.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Taoka Chemical financially healthy?
Taoka Chemical carries a debt-to-equity ratio of 0.04x and a current ratio of 2.01x, with a market beta of 0.39. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Taoka Chemical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Taoka Chemical (4113) the key facts are: market cap ¥11.8B, P/E 7.7x, revenue ¥33.2B, 52-week range 664-1547. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Taoka Chemical's full fundamentals live
Get Taoka Chemical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.